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All cells, including human hemopoietic cells and lines derived from them, possess 
numerous surface proteins. In most human leukocytes and lymphoid cell lines several 
dozen  proteins can  be  detected  in  membrane preparations,  but  so  far  only  those 
proteins  encoded  by  the  various  HLA  loci  have  been  extensively characterized. 
Virtually  nothing  is  known  about  the  great  majority of  lymphocyte  cell  surface 
proteins.  In  this  paper,  we  provide  preliminary characterization  of  a  previously 
undescribed  antigen  that  is  prominent on  the  surface  of all  dividing blood  cells 
examined and describe its distribution on a variety of normal and transformed human 
cells. 
Materials and Methods 
The cells examined were as follows: B lymphoblastoid lines: McB, Ramos, Laz 263, Mu, SB, 
JY, SzB, 22B, and MoB; T lymphoblastoid lines: CEM, HSB, Molt 4, YT4E, HPB-ALL, HPB- 
MLT, TALL-l, RPMI 8402, and MoT; null lymphoid lines:  REH and Nalm  1. Other lines 
examined were the macrophage line U937, the granulocyte line HL-60, and the erythroleukemia 
line K562.  Blood  cells examined included erythrocytes, granulocytes, monocytes, peripheral 
blood lymphocyte (PBL)  B cells, PBL T cells, PBL cells from three S6zary syndrome patients, 
thymocytes obtained during cardiac surgery on infants, and PBL T cells stimulated either with 
phytohemagglutinin (PHA)  (10 ~g//tl; Difco Laboratories, Detroit, Mich.) or irradiated allo- 
geneic B cells. PBL B and T cells were purified by passing fresh lymphocytes over columns that 
contained Sepharose conjugated to antibodies directed against  human IgG Fab fragments. 
Cells  passing through the column were  allowed to sit at 37°C for  1 h and nonadherent cells 
were taken as T  cells. Cells adhering after vigorous washing were used as purified monocytes. 
B cells were eluted from the column with a solution of human IgG, and E-rosetting was carried 
out with neuraminidase-treated sheep erythrocytes to remove any contaminating T cells. The 
non-blood cells examined included human embryonic lung fibroblasts (Flow Laboratories, Inc., 
Rockville, Md.) and a human melanoma cell line, SK-MEL-37, syngeneic with the B cell line 
Mu. All cells were cultured in RPMI-1640 medium that contained 10% fetal calf serum. 
Labehng.  107 cells were  cultured for 6  13 h with 0.5  mCi [35S]methionine  (New  England 
Nuclear, Boston, Mass.)  in methionine-free RPMI-1640 that contained 10~ dialyzed fetal calf 
serum. Typically, cell lines incorporated 60-80%, and unstimulated PBL T  cells 8-15%, of the 
[:~SS]methionine.  Surface radioiodination was carried out on 2 x  107 healthy, washed cells using 
0.5 mCi t2sI, and Iodogen (Pierce Chemical Co., Rockford, Ill.) as a catalyst in accordance with 
the  manufacturer's suggestions.  Labeled cells  were  washed  extensively and extracted  in  l'7, 
Nonidet P-40, 2 mM phenylmethylsulfonylfluoride  and  10 mM Tris-HCl, pH  7.4, for  1 h on 
ice. Extracts were centrifuged for  10 rain at  12,000 g, then used fresh or stored frozen. 
Antisera.  Sera prepared in New Zealand white rabbits (and immunogens) were as follows: 
A99 (CEM membranes) (1); C51  (PBL from a S6zary syndrome patient); nOD (T cells from a 
T cell ALL), given by Dr. L Chess (2); cALLa (common ALL PBL cells) absorbed to recognize 
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the cALL antigen, given by Dr. M. Greaves (3). Antisera were absorbed with either PBL cells 
(B cells, T cells, or unseparated) or B or T  lymphoblastoid lines. 
Radioimmunoprecipitation.  Radioimmunoprecipitations were carried out and analyzed as de- 
scribed  elsewhere  (4). Normally  1,000-10,000  cpm were loaded  for sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis (SDS-PAGE). Counts loaded are not listed in figure captions 
because so many factors (e.g., length of exposure, film type, and photographic processing) affect 
the intensity of bands as they appear in figures.  Radioactive markers (particularly methylated 
phosphorylase  [93,000  mol wt]  and  bovine serum  albumen  [69,000  mol wt])  were  used  to 
determine  molecular weights.  Fluorography was carried  out  using  Enhance  (New  England 
Nuclear)  and results were visualized on Kodak XRP, XR, or SB film (Eastman Kodak Co., 
Rochester, N. Y.) exposed at -70°C. 
Lectin-binding Analyses.  Lectin-binding analyses were carried out using lectins  from wheat 
germ, lentil,  and ricin conjugated to Sepharose beads (Vector General Inc., Woodland Hills, 
Calif.).  Aliquots of labeled  extracts were mixed with 0.1  ml washed,  pelleted  beads and  the 
mixture agitated  at  4°C in  lectin  buffer (10 mM Tris-HCI, pH  7.8, 0.14  M  NaCI, 0.1  mM 
MnCI2,  0.1  mM CaCI2,  and 0.2% Brij  97)  for 1 h.  Beads were then  washed  extensively and 
bound material eluted with the appropriate sugar (5%) in lectin buffer. Eluates were analyzed 
by SDS-PAGE both with and without immunoprecipitation. 
Fluorescence Analysis.  Healthy cells (5 ×  106) were washed and incubated at 4°C for 1 h with 
either normal rabbit serum or A99 antiserum. They were then washed three times with ice-cold 
RPMI-1640 and reacted for a further 45 min with fluoresceinated goat anti-rabbit IgG at 4°C. 
After three  additional  ice-cold washes,  cells  were examined  for fluorescence either  by light 
microscopy (with incident ultraviolet illumination)  or by the fluorescence-activated cell sorter 
(FACS) (BD FACS Systems, Mountain View, Calif.) 
Results 
Presence of the Antigen  on Hemopoietic  Cell Lines.  Even  after  absorption  with  B  cell 
lines,  most antisera prepared against  various human T  cells and T  cell lines precipi- 
tated  numerous  bands  from  radiolabeled  T  cell  lines.  Exceptions  to  this  were  the 
antisera aOD  and A99 each of which, after limited  absorption with syngeneic B cell 
lines,  reacted  primarily  with  a  major peptide  in 3nS-labeled  extract  from the  T  cell 
line CEM at an apparent  tool wt of 90,000 (reduced)  (Fig.  1 a and b, 90 K). The A99 
antiserum  reacted less strongly with an additional  band at  ~250,000 mol wt present 
on most cell lines. Several other sera prepared against human T  cells also precipitated 
a  90,000-tool wt  peptide  from CEM.  Immunoprecipitations  carried  out  with  aOD, 
A99, C51, or the other antisera on other T  cell lines (Molt 4, HSB, YT4E, HPB-ALL, 
HPB-MLT,  TALL-l,  MoT,  and  RPMI  8402)  and  B  lymphoid  lines  (McB,  SB, 
Ramos, 22B, MoB, Laz 263, and Mu [Fig. 1 el) showed that the antigen was expressed 
on all  of them.  Furthermore,  it  was also present  on the  macrophage line  U937,  the 
granulocytic line HL-60, the erythroleukemic line K562, and the null-cell lines Nalm 
1 and  REH  (Fig.  1 e).  If the  antisera  were  absorbed  on a  T  cell  line,  no reactivity 
against  the 90,000-tool wt  protein  present  on B  cell  lines remained.  After thorough 
absorption of all  the antisera  (including A99 and aOD)  with  B  lymphoblastoid cell 
lines (1 vol antiserum; 4 vol packed Laz 263, McB, or 22B cells), all reactivity against 
the 90,000-mol wt antigen  on CEM or HSB was abolished.  These results confirmed 
that the same antigen was present  on both B and T  cell lines.  Both [35S]methionine- 
and  a2~I-labeled  cell  extracts  gave  similar  results.  Iodination  generally  labeled  the 
protein  more heavily than  [35S]methionine. 
Because  the  90,000-mol  wt  peptide  was present  on all  available  hemopoietic cell 
lines,  human  embryonic  lung  fibroblasts  were  examined  as  an  example  of a  non- 
lymphoid-transformed cell type, and human melanoma cells (SK-MEL-37) as a  non- 
lymphoid-transformed cell type. The antigen was strongly expressed on the melanoma 1432  JUDD  ET  AL.  BRIEF  DEFINITIVE  REPORT 
FIc.! (left) and FIG. 2 (right).  Radioimmunoprecipitations analyzed on SDS-PAGE gradient gels 
under reducing conditions unless otherwise indicated. Fig, 1: (a) asS-CEM × aOD; (b) asS-GEM 
3fi  as  125  X  A99;  (c)  S-Mu  X  aOD;  (d)  S-SK-MEL-37  x  aOD;  (e)  S-REH  x  unabsorbed C51; (f)  I- 
125  25  125  3,5  PBLTXaOD;(g)  I-PBLTXA99  (h)  I-PBLBXaOD  (i)  I-PBLBXA99  (j)  S-PHA- 
stimulated PBL T X A99; and (k) asS-PHA-stimulated PBL T X aOD. 90 K, 90,000 tool wt. 
Ftc.  2.  (a)  t~I-Nalm  I  non-immunoprecipitated;  (h)  lasI-Nalm I  X otOD; (c)  125I-Natm 1 X 
acALL;  (d) asS-CEM x  aOD (not reduced); (e) asS-CEM eluted from wheat germ lectin X C51 
(unabsorbed); (f) ~S-CEM eluted from lentil lectin × C51 (unabsorbed); (g) ~S-CEM eluted from 
ricin lectin ×  (251 (unabsorbed); (h)  nsI-CEM non-immunoprecipitated; and (i)  t~I-YT4E non- 
immunoprecipitated. 200 K, 200,000 tool wt; 90 K, 90,000 tool wt. The 92,500-mol wt standard, 
methylated phosphorylase B, has a mobility between the novel 90K protein and the common ALL 
antigen (95,000 tool wt). 
line  (Fig.  1 d).  A  much weaker band was precipitated  from human embryonic lung 
fibroblasts. 
Distribution of the Antigen on Blood Cells.  Radioimmunoprecipitation  from iodinated 
PBL B and PBL T  cells failed to detect the 90,000-mol wt antigen (Fi~  I f-i). On one 
occasion, a very small amount of90,000-mol wt protein was seen in a  [  S]methionine- 
labeled preparation of PBL T  cells (see below). When nSI-labeled extracts were used, 
a  weak band was sometimes present in the same region of the gel, but it was also seen 
on precipitations  obtained  with  antisera  from which all  activity against  the 90,000- 
mol wt  band had been absorbed.  This  nonspecific contaminant  band was generally 
broader  and  of slightly  larger  size  (91,000-93,000  mol wt)  than  the  90,000-mol  wt 
peptide (Fig.  1 h and i). Weak bands of 52,000 and 68,000 mol wt were present on gels 
of lZ~I-labeled PBL T  cells immunoprecipitated  with A99 or aOD  but not on PBL B 
cells (Fig.  1 f-i). aOD and A99 have previously been shown to react with PBL T  cells 
but not with PBL B cells (1, 2). Antisera absorbed with PBL T  or PBL B cells retained 
the ability to recognize the 90,000-mol wt antigen from CEM extract, thus confirming 
that PBL B and T  cells lack the antigen. 
The 90,000-mol wt protein could not be precipitated  from l~I-labeled thymocytes, 
granulocytes, monocytes, or erythrocytes.  If separated  PBL T  cells were stimulated 
allogeneically  with  irradiated  B  cells  or  with  PHA,  radioimmunoprecipitation  re- 
vealed  that  the antigen  had  been  induced  and was abundant  on the surface of the 
resulting blast cells (Fig.  lj and k). A small percentage of dividing blast T  cells could 
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Metabolic labeling would amplify the contribution  made by a  few rapidly dividing 
cells in an otherwise resting population. Iodination would not be affected in this way 
by blast  cells and  90,000-mol  wt  antigen  was  never detected  on  PBL cells  by this 
method. 
In addition to being present on cell lines, the antigen occurred on several leukemic 
T  cells examined.  It was present  in the immunoprecipitates from the PBLs of three 
S~zary syndrome patients examined and must also have been present on the leukemic 
T  cells used as the immunogens in the preparation of aOD. 
Relationship to  the  Common ALL  Antigen.  The  common  ALL  antigen  (cALLa),  a 
protein  of similar  size  (95,000  mol  wt)  (3),  and  the  antigen  described  here  were 
independently precipitated (Fig. 2 b and c). The distribution of the two antigens was 
also different. On Nalm  1 for example, the 90,000-mol wt antigen and cALLa were 
both strongly expressed (Fig.  2 a-c). On REH, the 90,000-mol wt antigen  was 'weak 
(Fig.  I e), whereas cALLa was strong (3); while the reverse was true on CEM. cALLa 
could not be detected on any B cell lines, as previously reported (3). 
Characterization of the Antigen.  The antigen appeared as a polypeptide of 90,000 tool 
wt under reducing conditions. Under nonreducing conditions, the band at 90,000 tool 
wt disappeared to be replaced by another at -200,000 mol wt (Fig. 2d). The protein 
may occur normally as a disulphide bonded dimer. Because the 90,000-tool wt antigen 
can be surface iodinated  and antibodies against  it are absorbed by intact cells, it is 
obviously situated on the cell surface.  Lectin-binding experiments revealed that  the 
antigen is a  glycoprotein that binds to lentil and ricin but not significantly to wheat 
germ agglutinin  (Fig. 2e-g). 
Relative Abundance of the Antigen on Different Cell Lines.  Data from the FACS showed 
that CEM reacted more strongly with A99 than any other cell line tested. Other cell 
lines that reacted less strongly than CEM but were clearly positive included the null- 
cell line Nalm  1, the B cell line MoB, and the granulocytic line HL-60. Two B cell 
lines (JY and SzB) and the null-cell line REH appeared essentially negative, similar 
to Laz 007  (1).  However, radioimmunoprecipitation had previously revealed a  weak 
90,000-mol wt band on REH (Fig.  1 e). Radioimmunoprecipitation, a highly concen- 
trative procedure, is more sensitive than immunofluorescence analysis. 
The amount  of 90,000-tool  wt  antigen  expressed appeared to differ considerably 
from one line to another. This conclusion was supported by the immunoprecipitation 
data and non-immunoprecipitated, surface-iodination  analyses as well as the FACS 
results. On surface-iodinated CEM, non-immunoprecipitated gel analysis showed the 
band at 90,000 mol wt to be one of the major three or four peptides visible (Fig. 2 h). 
Similar  experiments  revealed  that  the  90,000-tool  wt  band  was  a  less  significant 
protein on most other lines including some T  cell lines (YT4E, Fig. 2 i). 
No single class of cells  (e.g.,  null  cells,  B  cells,  or T  cells)  expressed a  consistent 
amount of the antigen.  For instance, the null-cell line Nalm 1 possessed considerable 
amounts of the antigen, whereas the amount present on REH, another null-cell line, 
was very low  (Fig.  1 e  and  Fig.  2 a  and  b).  Most  lines expressed considerably  more 
90,000-mol wt antigen than REH but less than GEM. 
Discussion 
This paper describes a  novel blast antigen of 90,000 mol wt, clearly distinct in size 
as well as cell distribution  from the common ALL antigen discovered by Sutherland 
et al. (3) and from band 3, the 90,000-mol wt protein on erythrocytes (fi) that was not 
precipitated  by odDD. Our data should be compared to several recent  reports. Saito 1434  JUDD ET AL.  BRIEF  DEFINITIVE REPORT 
et al.  (6) characterized a sialoglycoprotein from Molt 4 that has an estimated 95,000 
mol  wt,  although  cALLa  is  not  present  on  Molt  4.  They  have  not  detailed  the 
distribution of this protein on other cell lines and it differs from the protein described 
here in certain respects. The 90,000-tool  wt protein binds to ricin and lentil but not 
WGA,  whereas  the  95,000-mol  wt  protein  binds  to  ricin  and  WGA.  Under  non- 
reducing conditions, the 90,000-mol wt peptide is replaced by a band at 200,000 mol 
wt, whereas the 95,000-mol wt protein remains at the same molecular weight. Billings 
et  al.  (7)  outlined  serologically  the  distribution  of a  blast  cell  antigen  on  various 
lymphoid cells and cell  lines.  They used an antiserum  prepared against  CEM ceils 
and studied its distribution by cytotoxicity. Although they examined certain cell types 
that we have not  (CML, CLL, AML, and ALL ceils) and we have looked at others 
they  omitted  (S6zary cells,  granulocytes,  thymocytes, and  erythrocytes),  there  is  a 
general  similarity  in  the  results.  One  point  at  which  the  results  differ  is  that  the 
90,000-mol wt antigen is absent from monocytes but their antigen is present on these 
cells.  Because they have not characterized the protein(s)  their antiserum recognizes, 
it is not yet possible to say that the antisera react with the same antigen.  It is worth 
noting  that  the  A99  antiserum  was  made against  CEM  membranes also.  Yin  and 
Stossel  (8)  described  a  91,000-mol  wt  protein  named  gelsolin  isolated  from  lung 
macrophages of adjuvant-primed rabbits. This protein catalyzes the reversible break- 
down of actin filaments in the presence of Ca  ++ and is thought to exist as a dimer in 
vivo. The protein is believed to occur in the peripheral part of the cytoplasm but it is 
unknown  whether  it  is  also  present  on  the  membrane.  The 90,000-tool  wt  protein 
described here could  be a  human equivalent  of this rabbit protein, although  it  has 
not been detected on monocytes from peripheral blood. Another possibility is that the 
90,000-mol  wt protein could represent the  100,000-mol wt glycoprotein found to be 
associated with malignancy in a  variety of different tumors by Bramwell and Harris 
(9).  Expression of the antigen may be enhanced on some malignant cells. 
The A99  antiserum  has recently  been  described  as  reacting with  several T  cell- 
specific components of CEM cell membranes (1).  The A99 preparation  used  in  the 
present  study was not  as thoroughly absorbed as that  described  previously. Among 
several proteins  radioimmunoprecipitated  by this  antiserum  under  reducing condi- 
tions (1) were bands at 96,000 mol wt and 195,000 mol wt; the band at 96,000 mol wt 
disappeared under nonreducing conditions (1).  It seems likely that this 96,000-mol wt 
band is the 90,000-mol wt blast antigen described here, and if so, it is definitely not 
T  cell  specific.  A  further  possibility  is  that  the  195,000-mol  wt  band  represents 
incompletely reduced 90,000-mol wt protein. 
Friedman et al.  (2)  reported that ~OD is cytotoxic for a  subpopulation of PBL T 
cells thought to possess helper activity. It is possible that the weak bands precipitated 
by aOD from PBL T  cells between 52,000 and 60,000 mol wt and at 68,000 tool wt 
represent  this  reactivity. The A99  antiserum  also  recognizes  these  proteins  and  an 
additional  weak band at  39,000  mol wt.  None of these bands could be precipitated 
from  PBL  B  cells by either  antiserum,  aOD  did  precipitate  some  high  molecular 
weight  bands from both  PBL T  and  PBL B  cells that  were not  present  in  immune 
precipitates using A99 (Fig.  1 f, h). 
These results obtained here suggest that this 90,000-mol wt antigen is present on all 
cell lines derived from transformed hemopoietic cells, although the amount of antigen 
present  may  vary  considerably.  Under  normal  in  vivo  circumstances,  blast  cells 
generated  during infections such as infectious mononucleosis are probably the only 
hemopoietic cells expressing this antigen. In malignant disorders, it was expressed on JUDD ET AL.  BRIEF  DEFINITIVE REPORT  1435 
all  leukemic blasts examined.  Antisera against  the antigen could provide a  valuable 
tool for identifying leukemic blast cells. This protein may be purified for further study 
using a  lentil-lectin  column followed by an immunoaffinity column. ~ 
Summary 
Radioimmunoprecipitation  followed by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis  was  used  to  study  the  distribution  on  human  lymphoid  cells  of a 
previously undescribed  surface  antigen  recognized by several  heteroantisera.  A  gly- 
coprotein with a  90,000 mol wt  (under reducing conditions)  was detected on all cell 
lines  tested  including  T,  B,  null,  and  myeloid  cell  lines,  although  the  amount  of 
antigen present  varied considerably. The antigen was absent  from normal peripheral 
blood lymphocytes (PBL), B  and T  cells,  monocytes, granulocytes, thymocytes, and 
erythrocytes.  After  stimulation  with  lectins  or  allogeneic  B  cells,  the  antigen  was 
induced on PBL T  cells. A limited number of leukemic T  cells tested all expressed the 
antigen, as did a  melanoma cell line and human embryonic lung fibroblasts.  Hence, 
the antigen was present only on dividing lymphoid cells and absent from nondividing 
cells, but was also present on the two examples of dividing non-lymphoid cells tested. 
Under nonreducing conditions, the 90,000-mol wt band normally present disappeared 
to be  replaced  by another  at  ~200,000  mol wt.  The  glycoprotein  bound  to lectins 
from lentil  and  ricin,  but  not  to wheat  germ agglutinin.  It could be readily labeled 
metabolically  by  [~S]methionine  or  by  surface  iodination,  and  appeared  to  be  a 
major membrane protein on some cell lines. 
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